Role of Nrf2 in Fracture Healing: Clinical Aspects of Oxidative Stress
Overview
Authors
Affiliations
Fracture healing is a natural process that recapitulates embryonic skeletal development. In the early phase after fracture, reactive oxygen species (ROS) are produced under inflammatory and ischemic conditions due to vessel injury and soft tissue damage, leading to cell death. Usually, such damage during the course of fracture healing can be largely prevented by protective mechanisms and functions of antioxidant enzymes. However, intrinsic oxidative stress can cause excessive toxic radicals, resulting in irreversible damage to cells associated with bone repair during the fracture healing process. Clinically, patients with type-2 diabetes mellitus, osteoporosis, habitual drinkers, or heavy smokers are at risk of impaired fracture healing due to elevated oxidative stress. Although increased levels of oxidative stress markers upon fracture and effects of antioxidants on fracture healing have been reported, a detailed understanding of what causes impaired fracture healing under intrinsic conditions of oxidative stress is lacking. Nuclear factor erythroid 2-related factor 2 (Nrf2) has been identified as a key transcriptional regulator of the expression of antioxidants and detoxifying enzymes. It further not only plays a crucial role in preventing degenerative diseases in multiple organs, but also during fracture healing. This narrative review evaluates the influence of intrinsic oxidative stress on fracture healing and sheds new light on the intriguing role of Nrf2 during bone regeneration in pathological fractures.
Supersulfides contribute to joint homeostasis and bone regeneration.
Maemura M, Morita M, Ogata S, Miyamoto Y, Ida T, Shibusaka K Redox Biol. 2025; 81:103545.
PMID: 39983344 PMC: 11893308. DOI: 10.1016/j.redox.2025.103545.
Yang P, Wang H, Meng L, Kou Y, Bu J, Li M J Mol Histol. 2025; 56(2):86.
PMID: 39928245 DOI: 10.1007/s10735-025-10358-x.
Li P, Alenazi K, Dally J, Woods E, Waddington R, Moseley R Front Dent Med. 2025; 5:1464009.
PMID: 39917650 PMC: 11797775. DOI: 10.3389/fdmed.2024.1464009.
Nrf2 Activation as a Therapeutic Target for Flavonoids in Aging-Related Osteoporosis.
Messeha S, Fidudusola F, Gendy S, Latinwo L, Odewumi C, Soliman K Nutrients. 2025; 17(2).
PMID: 39861398 PMC: 11767473. DOI: 10.3390/nu17020267.
Asperuloside alleviates osteoporosis by promoting autophagy and regulating Nrf2 activation.
Huang F, Wang Y, Liu J, Cheng Y, Zhang X, Jiang H J Orthop Surg Res. 2024; 19(1):855.
PMID: 39702357 PMC: 11658297. DOI: 10.1186/s13018-024-05320-8.